BioNTech SE

BNTX

NASDAQ. Currency in USD

168.56 -6.69 ( -3.82% )

Real time prices: December 19

Date 2021 2020 2019 2018
Gross Profit 15.12B 422.99M 91.23M 113.89M
Revenue 18.98B 482.32M 108.59M 127.58M
Cost Of Revenue 3.86B 59.33M 17.36M 13.69M
Cost Of Goods And Services Sold 3.86B 59.33M 17.36M 13.69M
Operating Income 15.28B -82.42M -181.52M -53.85M
Selling General And Administrative 278.50M 86.91M 40.69M 24.05M
Research And Development - 647.06M 226.47M 143.04M
Operating Expenses 200.10M 512.41M 272.75M 167.74M
Investment Income Net - - - -
Net Interest Income -25.80M -3.49M -263,000 227,000
Interest Income 1.50M 1.56M 1.78M 2.00M
Interest Expense 5.40M 2.00M 1.72M 1.72M
Non Interest Income - - - -
Other Non Operating Income - - 0 0
Depreciation - - - -
Depreciation And Amortization 75.20M 38.74M 33.90M 21.98M
Income Before Tax 15.05B -145.80M -179.44M -47.66M
Income Tax Expense 4.75B -161.00M -268,000 600,000
Interest And Debt Expense - - - -
Net Income From Continuing Operations 10.29B 15.20M -179.17M -48.26M
Comprehensive Income Net Of Tax - - - -
Ebitda 15.13B -105.06M -143.71M -23.71M
Ebit 15.05B -143.80M -177.61M -45.70M
Net Income 10.29B 15.20M -179.06M -48.02M